Literature DB >> 29600987

The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging.

T Soomro1, J Talks1.   

Abstract

PurposeTo assess OCT angiography (OCTA) effectiveness at detecting choroidal neovascularization (CNV) in cases of suspected neovascular age related macular degeneration (nAMD), chronic central serous retinopathy (cCSR) and pathological myopia compared to FFA and how it compares to a multimodal approach (OCT, FFA and ICGA) for detecting the vascular network.MethodsThis was a retrospective observational cohort study of patients who had clinical and/or OCT findings suggestive of CNV, having further investigation with FFA, with or without ICG, and had same day OCTA using the Heidelberg Spectralis OCT2 beta angiography module. Multimodal imaging interpretation was compared to OCTA images. OCTA images were also analysed for inter-rater reliability (using kappa statistic). The diagnostic accuracy of OCTA was compared to FFA (using Cochran's Q, p<0.05). OCTA was also compared to a multimodal approach in defining a vascular network.ResultsOverall sensitivity of OCTA compared to FFA was 71% and specificity of 81% (p=0.108). Subgroup analysis for OCTA vs FFA for detecting classic nAMD/type II CNV sensitivity was 100% and specificity of 76% (p<0.05). OCTA vs FFA for detecting occult nAMD/type-I CNV sensitivity was 47% and specificity of 76%, (p=0.248). OCTA was better than FFA at defining a vascular network overall, when OCT was suspicious (59% vs 49%).ConclusionsOCTA was better at detecting classic nAMD/type II CNV compared to FFA and for defining a vascular network in nAMD compared to FFA and ICGA. It was able to aid in making the diagnosis in cases where evidence of CNV was uncertain following FFA/ICGA.

Entities:  

Mesh:

Year:  2018        PMID: 29600987      PMCID: PMC5898879          DOI: 10.1038/eye.2018.2

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  20 in total

1.  Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.

Authors:  Marco Antonio Bonini Filho; Talisa E de Carlo; Daniela Ferrara; Mehreen Adhi; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

2.  Type 1 Choroidal Neovascularization Lesion Size: Indocyanine Green Angiography Versus Optical Coherence Tomography Angiography.

Authors:  Eliana Costanzo; Alexandra Miere; Giuseppe Querques; Vittorio Capuano; Camille Jung; Eric H Souied
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

3.  A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization.

Authors:  Maiko Inoue; Jesse J Jung; Chandrakumar Balaratnasingam; Kunal K Dansingani; Elona Dhrami-Gavazi; Mihoko Suzuki; Talisa E de Carlo; Abtin Shahlaee; Michael A Klufas; Adil El Maftouhi; Jay S Duker; Allen C Ho; Maddalena Quaranta-El Maftouhi; David Sarraf; K Bailey Freund
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

4.  Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography.

Authors:  Richard F Spaide; James M Klancnik; Michael J Cooney
Journal:  JAMA Ophthalmol       Date:  2015-01       Impact factor: 7.389

5.  Split-spectrum phase-gradient optical coherence tomography angiography.

Authors:  Gangjun Liu; Yali Jia; Alex D Pechauer; Rahul Chandwani; David Huang
Journal:  Biomed Opt Express       Date:  2016-07-11       Impact factor: 3.732

6.  Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study.

Authors:  Diana V Do; Emily W Gower; Sandra D Cassard; David Boyer; Neil M Bressler; Susan B Bressler; Jeffrey S Heier; Joan L Jefferys; Lawrence J Singerman; Sharon D Solomon
Journal:  Ophthalmology       Date:  2012-01-31       Impact factor: 12.079

7.  Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration.

Authors:  Yali Jia; Steven T Bailey; David J Wilson; Ou Tan; Michael L Klein; Christina J Flaxel; Benjamin Potsaid; Jonathan J Liu; Chen D Lu; Martin F Kraus; James G Fujimoto; David Huang
Journal:  Ophthalmology       Date:  2014-03-27       Impact factor: 12.079

8.  Optical coherence tomography angiography of myopic choroidal neovascularisation.

Authors:  Lea Querques; Chiara Giuffrè; Federico Corvi; Ilaria Zucchiatti; Adriano Carnevali; Luigi A De Vitis; Giuseppe Querques; Francesco Bandello
Journal:  Br J Ophthalmol       Date:  2016-08-16       Impact factor: 4.638

9.  Spectral-domain optical coherence tomography angiography of choroidal neovascularization.

Authors:  Talisa E de Carlo; Marco A Bonini Filho; Adam T Chin; Mehreen Adhi; Daniela Ferrara; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  Ophthalmology       Date:  2015-03-17       Impact factor: 12.079

Review 10.  A review of optical coherence tomography angiography (OCTA).

Authors:  Talisa E de Carlo; Andre Romano; Nadia K Waheed; Jay S Duker
Journal:  Int J Retina Vitreous       Date:  2015-04-15
View more
  3 in total

1.  Interobserver Agreement of Novel Classification of Central Serous Chorioretinopathy.

Authors:  Niroj K Sahoo; Deepika C Parameshwarappa; Mahima Jhingan; Filippo Tatti; Claudio Iovino; Enrico Peiretti
Journal:  Cureus       Date:  2022-06-14

2.  ASSESSING THE ACTIVITY OF MYOPIC CHOROIDAL NEOVASCULARIZATION: Comparison Between Optical Coherence Tomography Angiography and Dye Angiography.

Authors:  Songshan Li; Limei Sun; Xiujuan Zhao; Sijian Huang; Xiaoling Luo; Aiyuan Zhang; Chonglin Chen; Zhirong Wang; Chengxi Liu; Xiaoyan Ding
Journal:  Retina       Date:  2020-09       Impact factor: 3.975

Review 3.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.